These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16247474)

  • 1. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
    Longley DB; Wilson TR; McEwan M; Allen WL; McDermott U; Galligan L; Johnston PG
    Oncogene; 2006 Feb; 25(6):838-48. PubMed ID: 16247474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-FLIP: a key regulator of colorectal cancer cell death.
    Wilson TR; McLaughlin KM; McEwan M; Sakai H; Rogers KM; Redmond KM; Johnston PG; Longley DB
    Cancer Res; 2007 Jun; 67(12):5754-62. PubMed ID: 17575142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
    Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
    J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.
    Hietakangas V; Poukkula M; Heiskanen KM; Karvinen JT; Sistonen L; Eriksson JE
    Mol Cell Biol; 2003 Feb; 23(4):1278-91. PubMed ID: 12556488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.
    Galligan L; Longley DB; McEwan M; Wilson TR; McLaughlin K; Johnston PG
    Mol Cancer Ther; 2005 Dec; 4(12):2026-36. PubMed ID: 16373718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 protein influences the sensitivity of testicular germ cells to mono-(2-ethylhexyl) phthalate-induced apoptosis by increasing the membrane levels of Fas and DR5 and decreasing the intracellular amount of c-FLIP.
    Chandrasekaran Y; Richburg JH
    Biol Reprod; 2005 Jan; 72(1):206-13. PubMed ID: 15371270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
    Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
    Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.
    Sharp DA; Lawrence DA; Ashkenazi A
    J Biol Chem; 2005 May; 280(19):19401-9. PubMed ID: 15760909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteasome is required for rapid initiation of death receptor-induced apoptosis.
    Sohn D; Totzke G; Essmann F; Schulze-Osthoff K; Levkau B; Jänicke RU
    Mol Cell Biol; 2006 Mar; 26(5):1967-78. PubMed ID: 16479014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.
    Song JH; Song DK; Pyrzynska B; Petruk KC; Van Meir EG; Hao C
    Brain Pathol; 2003 Oct; 13(4):539-53. PubMed ID: 14655759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
    Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
    Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
    Lees A; McIntyre AJ; Crawford NT; Falcone F; McCann C; Holohan C; Quinn GP; Roberts JZ; Sessler T; Gallagher PF; Gregg GMA; McAllister K; McLaughlin KM; Allen WL; Egan LJ; Ryan AE; Labonte-Wilson MJ; Dunne PD; Wappett M; Coyle VM; Johnston PG; Kerr EM; Longley DB; McDade SS
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17808-17819. PubMed ID: 32661168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.